Influenza activity remains elevated in most of the country, according to the latest FluView report from the CDC for the week of January 13-19.
Influenza activity remains elevated in most of the country, according to the latest FluView report from the CDC for the week of January 13-19.
Some national indicators are declining while others are increasing. In general, influenza-like-illness activity levels are declining in the South, Southeast, New England, and the Midwest, but increasing in the Mid-Atlantic, Southwest, and the Northwest.
Key indicators reflecting severity, such as hospitalizations and deaths, increased significantly again this week, with the greatest impact among people aged 65 and older. Of the 6,191 influenza-associated hospitalizations that have been reported this season, 50.1% have been among people aged 65 and older.
“While some part of the United States continue to experience declines in influenza activity, there are others that are still experiencing increases in the virus resulting in hospitalizations and death,” said Formulary Advisor Abimbola Farinde, PharmD, MS, clinical staff pharmacist at Clear Lake Regional Medical Center, in Webster, Texas.
“It is important for healthcare providers to reiterate to the public the importance of vaccination as a preventive measure, and the use of antiviral treatments as a means of curtailing the rising incidences and at times possible fatality that can result from untreated flu-related complications,” Dr Farinde said.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Published: November 25th 2024 | Updated: November 25th 2024CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Read More
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More